Nanfang Hospital of Southern Medical University

Guangzhou 510515

4 studies enrolling now · 9 studies all time

What they study most

Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Deep Venous Thrombosis, IgA Nephropathy, Immune Thrombocytopenia (ITP), Immunoglobulin A Nephropathy, Invasive Aspergillosis, Leukemia, Lymphoma, Small Lymphocytic, Non-small Cell Lung Cancer, Pulmonary Embolism, Relapsed or Refractory Peripheral T Cell Lymphoma

Studies at this site

• A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Recruiting now
• Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer — Recruiting now
• A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia — Recruiting now
• Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission — Recruiting now
• Atrasentan in Patients With IgA Nephropathy — Running, not enrolling
• A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE — Stopped early
• A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE — Stopped early
• Olorofim Aspergillus Infection Study — Running, not enrolling
• Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8) — Completed